@kmart_fit's TRT injection tips need some corrections

What did @kmart_fit actually say?

The creator warned against reusing injection needles, citing something called "micro splintering" that damages the needle tip after a single use. They claimed this puts you at "extreme risk for infection and post-injection pain" and advised always switching needles before the next injection. The core advice, don't reuse needles, is correct. The explanation given for why is partially grounded in reality but stretched significantly beyond what the evidence clearly supports.

Does the science back this up?

The needle-dulling claim has real support. Research on needle reuse, largely from the diabetes and insulin delivery literature, confirms that needles degrade meaningfully after a single puncture. A study by Hirsch et al. (2012, Diabetes Technology and Therapeutics) using electron microscopy showed that lancet and needle tips develop visible barbing and tip deformation after one use. The term "micro splintering" is not a standard clinical term, but the physical phenomenon it describes, tip deformation, is well documented.

On infection risk, the evidence is more nuanced. The primary infection risk from needle reuse in home injection settings is typically contamination from skin flora introduced during the first use, not mechanical tip damage itself. A systematic review by Spollett et al. (2012, Diabetes Educator) found that while reuse is discouraged, infection rates attributable specifically to tip deformation were not well-quantified. Calling it an "extreme risk" for infection overstates what the data actually shows for single-reuse scenarios.

What did they get wrong (or right)?

Credit where it is due: the recommendation to use a new needle for every injection is correct, and it is what any responsible prescriber, pharmacist, or clinical guideline would tell you. FDA guidance and manufacturer labeling for injection devices consistently state that needles are single-use only. That part is not controversial.

Where the creator goes too far is the causal chain they construct. Framing "micro splintering" as the primary driver of "extreme" infection risk is misleading. Tip deformation does increase post-injection pain and tissue trauma, a point backed by the needle reuse literature. But infection risk from a single reuse is driven more by contamination and improper technique than by a mechanically damaged tip. Using fear language like "extreme risk" for infection from one reuse, without distinguishing between pain risk and infection risk, muddies the actual concern. It also risks credibility: if someone reuses a needle once without incident, they may dismiss the advice entirely because the "extreme risk" framing feels exaggerated.

What should you actually know?

If you are on testosterone cypionate or any injectable therapy, use a new needle every single time. This is not a gray area. Here is why it actually matters, stripped of the dramatization.

• Tip deformation after one use increases injection pain and can cause more tissue microtrauma at the injection site. Over time, repeated trauma contributes to scar tissue buildup, which affects absorption.
• Reused needles carry skin bacteria from the first insertion. Combined with an oil-based carrier like sesame or cottonseed oil, which is common in testosterone cypionate formulations, this creates a low-grade environment for post-injection nodules or abscess formation if technique is poor.
• Post-injection pain (PIP) from oil-based testosterone preparations is already a common complaint. A dull or damaged needle tip makes this significantly worse.
• Syringes and needles supplied for home use are regulated as single-use devices. Reusing them is technically an off-label deviation from their intended design.

The bottom line: the advice is right. The mechanism described is real but oversimplified. Follow the single-use rule for the right reasons, tissue integrity and contamination control, not because one reuse guarantees a dramatic infection outcome.